scholarly article | Q13442814 |
P2093 | author name string | Tadasuke Ooka | |
Tetsuya Hayashi | |||
Toru Tobe | |||
Hilo Yen | |||
Atsushi Iguchi | |||
Nakaba Sugimoto | |||
P2860 | cites work | Bacterial effector binding to ribosomal protein s3 subverts NF-kappaB function | Q24293521 |
Toll-like receptor signalling | Q24570126 | ||
An extensive repertoire of type III secretion effectors in Escherichia coli O157 and the role of lambdoid phages in their dissemination | Q24678382 | ||
Regulation and function of IKK and IKK-related kinases | Q28268930 | ||
The two NF-kappaB activation pathways and their role in innate and adaptive immunity | Q29614355 | ||
Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli | Q29615309 | ||
The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling | Q29615457 | ||
Pathogenic Escherichia coli | Q29616738 | ||
Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism | Q29619866 | ||
The type III effectors NleE and NleB from enteropathogenic E. coli and OspZ from Shigella block nuclear translocation of NF-kappaB p65. | Q33582255 | ||
A genetic locus of enteropathogenic Escherichia coli necessary for the production of attaching and effacing lesions on tissue culture cells | Q33834748 | ||
Supermolecular structure of the enteropathogenic Escherichia coli type III secretion system and its direct interaction with the EspA-sheath-like structure | Q33944789 | ||
War and peace at mucosal surfaces | Q33983437 | ||
Enteropathogenic Escherichia coli contains a putative type III secretion system necessary for the export of proteins involved in attaching and effacing lesion formation | Q34022530 | ||
The Shigella flexneri effector OspG interferes with innate immune responses by targeting ubiquitin-conjugating enzymes | Q34048081 | ||
Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA. | Q34285636 | ||
Families of zinc metalloproteases. | Q34325403 | ||
Diarrhoeagenic Escherichia coli--an emerging problem? | Q34466495 | ||
Essential role of the type III secretion system effector NleB in colonization of mice by Citrobacter rodentium | Q34492843 | ||
The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus | Q34543723 | ||
The effector repertoire of enteropathogenic E. coli: ganging up on the host cell | Q34921824 | ||
Phosphorylation of NF-kappaB p65 at Ser468 controls its COMMD1-dependent ubiquitination and target gene-specific proteasomal elimination | Q34959023 | ||
Attachment of a noninvasive enteric pathogen, enteropathogenic Escherichia coli, to cultured human intestinal epithelial monolayers induces transmigration of neutrophils | Q35527637 | ||
Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation | Q36104202 | ||
Caspase-3-mediated cleavage of p65/RelA results in a carboxy-terminal fragment that inhibits IkappaBalpha and enhances HIV-1 replication in human T lymphocytes | Q37074306 | ||
Attaching and effacing activities of rabbit and human enteropathogenic Escherichia coli in pig and rabbit intestines. | Q37106331 | ||
Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemorrhagic Escherichia coli | Q37394514 | ||
Chlamydial CT441 is a PDZ domain-containing tail-specific protease that interferes with the NF-kappaB pathway of immune response | Q37859424 | ||
Enteropathogenic Escherichia coli (EPEC) inactivate innate immune responses prior to compromising epithelial barrier function. | Q40153854 | ||
An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses | Q40198172 | ||
Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation | Q40328896 | ||
Characterization of two non-locus of enterocyte effacement-encoded type III-translocated effectors, NleC and NleD, in attaching and effacing pathogens | Q40380291 | ||
Actin accumulation at sites of bacterial adhesion to tissue culture cells: basis of a new diagnostic test for enteropathogenic and enterohemorrhagic Escherichia coli | Q40426825 | ||
Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions | Q41633390 | ||
Complete genome sequence and comparative genome analysis of enteropathogenic Escherichia coli O127:H6 strain E2348/69. | Q41823804 | ||
The type III secretion effector NleE inhibits NF-kappaB activation | Q41893338 | ||
Systematic identification and sequence analysis of the genomic islands of the enteropathogenic Escherichia coli strain B171-8 by the combined use of whole-genome PCR scanning and fosmid mapping | Q42227031 | ||
Suppression of NF-kappa B activation and proinflammatory cytokine expression by Shiga toxin-producing Escherichia coli | Q42436813 | ||
Complete genome sequence of enterohemorrhagic Escherichia coli O157:H7 and genomic comparison with a laboratory strain K-12. | Q42645426 | ||
A cloned pathogenicity island from enteropathogenic Escherichia coli confers the attaching and effacing phenotype on E. coli K-12. | Q54574143 | ||
Double-joint PCR: a PCR-based molecular tool for gene manipulations in filamentous fungi | Q62090223 | ||
SOCS-1 participates in negative regulation of LPS responses | Q78518680 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 12 | |
P921 | main subject | NF-κB | Q411114 |
P304 | page(s) | e1001231 | |
P577 | publication date | 2010-12-16 | |
P1433 | published in | PLOS Pathogens | Q283209 |
P1476 | title | NleC, a type III secretion protease, compromises NF-κB activation by targeting p65/RelA | |
P478 | volume | 6 |
Q27315131 | A Family of Salmonella Type III Secretion Effector Proteins Selectively Targets the NF-κB Signaling Pathway to Preserve Host Homeostasis |
Q58572728 | A Metalloprotease Homolog Venom Protein From a Parasitoid Wasp Suppresses the Toll Pathway in Host Hemocytes |
Q33737576 | A Type III Effector NleF from EHEC Inhibits Epithelial Inflammatory Cell Death by Targeting Caspase-4 |
Q35228516 | A type III effector protease NleC from enteropathogenic Escherichia coli targets NF-κB for degradation |
Q27026551 | Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection |
Q37871646 | Always one step ahead: How pathogenic bacteria use the type III secretion system to manipulate the intestinal mucosal immune system |
Q35191956 | Attaching and effacing bacterial effector NleC suppresses epithelial inflammatory responses by inhibiting NF-κB and p38 mitogen-activated protein kinase activation. |
Q33623288 | Bacteria fighting back: how pathogens target and subvert the host innate immune system |
Q26766446 | Bacterial Toxins as Pathogen Weapons Against Phagocytes |
Q38123136 | Bacterial interference with canonical NFκB signalling. |
Q38105533 | Bacterial subversion of host innate immune pathways |
Q38053703 | Bovine innate and adaptive immune responses against Escherichia coli O157:H7 and vaccination strategies to reduce faecal shedding in ruminants |
Q38318508 | Bringing down the host: enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways |
Q48123982 | Comparative genomics reveals differences in mobile virulence genes of Escherichia coli O103 pathotypes of bovine fecal origin |
Q50020373 | Cooperative Immune Suppression by Escherichia coli and Shigella Effector Proteins |
Q35867616 | Correlating levels of type III secretion and secreted proteins with fecal shedding of Escherichia coli O157:H7 in cattle |
Q37597305 | Cyclic dinucleotides and the innate immune response |
Q37619425 | Detection of enteric pathogens by the nodosome |
Q38718756 | Distinct Roles of the Antiapoptotic Effectors NleB and NleF from Enteropathogenic Escherichia coli |
Q40213403 | Down the rabbit hole: Is necroptosis truly an innate response to infection? |
Q26991857 | Effector triggered manipulation of host immune response elicited by different pathotypes of Escherichia coli |
Q28547711 | Enteropathogenic Escherichia coli Uses NleA to Inhibit NLRP3 Inflammasome Activation |
Q33899677 | Enteropathogenic Escherichia coli inhibits type I interferon- and RNase L-mediated host defense to disrupt intestinal epithelial cell barrier function |
Q34177961 | Enteropathogenic and enterohaemorrhagic Escherichia coli: even more subversive elements |
Q36396783 | Enterotoxigenic Escherichia coli prevents host NF-κB activation by targeting IκBα polyubiquitination |
Q38696636 | Epithelial cells detect functional type III secretion system of enteropathogenic Escherichia coli through a novel NF-κB signaling pathway. |
Q37218224 | Escherichia coli Type III Secretion System 2 ATPase EivC Is Involved in the Motility and Virulence of Avian Pathogenic Escherichia coli |
Q37348920 | Escherichia coli virulence protein NleH1 interaction with the v-Crk sarcoma virus CT10 oncogene-like protein (CRKL) governs NleH1 inhibition of the ribosomal protein S3 (RPS3)/nuclear factor κB (NF-κB) pathway |
Q34198962 | EspG of enteropathogenic and enterohemorrhagic E. coli binds the Golgi matrix protein GM130 and disrupts the Golgi structure and function |
Q47351983 | Eukaryotic-like Kinase Expression in Enterohemorrhagic Escherichia coli: Potential for Enhancing Host Aggressive Inflammatory Response |
Q42233920 | Global Regulator of Virulence A (GrvA) Coordinates Expression of Discrete Pathogenic Mechanisms in Enterohemorrhagic Escherichia coli through Interactions with GadW-GadE. |
Q38295538 | Hijacking of death receptor signaling by bacterial pathogen effectors |
Q35737256 | Hyperinvasive Meningococci Induce Intra-nuclear Cleavage of the NF-κB Protein p65/RelA by Meningococcal IgA Protease |
Q24297066 | IKKβ phosphorylation regulates RPS3 nuclear translocation and NF-κB function during infection with Escherichia coli strain O157:H7 |
Q40604251 | Identification of a Distinct Substrate-binding Domain in the Bacterial Cysteine Methyltransferase Effectors NleE and OspZ. |
Q36466792 | Identification of an N-terminal truncation of the NF-κB p65 subunit that specifically modulates ribosomal protein S3-dependent NF-κB gene expression. |
Q36032316 | Inhibition of Nuclear Transport of NF-ĸB p65 by the Salmonella Type III Secretion System Effector SpvD. |
Q37214160 | Interference with nuclear factor kappaB signaling pathway by pathogen-encoded proteases: global and selective inhibition |
Q34595840 | Intracellular trafficking of AIP56, an NF-κB-cleaving toxin from Photobacterium damselae subsp. piscicida |
Q26822456 | Killing two birds with one stone: trans-kingdom suppression of PAMP/MAMP-induced immunity by T3E from enteropathogenic bacteria |
Q35636588 | Manipulation of kinase signaling by bacterial pathogens |
Q35163621 | Metalloprotease NleC suppresses host NF-κB/inflammatory responses by cleaving p65 and interfering with the p65/RPS3 interaction |
Q35108874 | Microbial strategies for antagonizing Toll-like-receptor signal transduction |
Q38994595 | Modulation of host signaling in the inflammatory response by enteropathogenic Escherichia coli virulence proteins |
Q28079739 | Modulation of the Inflammasome Signaling Pathway by Enteropathogenic and Enterohemorrhagic Escherichia coli |
Q28083042 | Modulation of the host innate immune and inflammatory response by translocated bacterial proteins |
Q91964035 | Molecular Mechanisms That Define Redox Balance Function in Pathogen-Host Interactions-Is There a Role for Dietary Bioactive Polyphenols? |
Q64063136 | NF-κB Signaling in Macrophages: Dynamics, Crosstalk, and Signal Integration |
Q49950912 | NleB/SseK effectors from Citrobacter rodentium, Escherichia coli, and Salmonella enterica display distinct differences in host substrate specificity. |
Q42152411 | Pathogen blocks host death receptor signalling by arginine GlcNAcylation of death domains |
Q58610410 | Phosphothreonine Lyase Promotes p65 Degradation in a Mitogen-Activated Protein Kinase/Mitogen- and Stress-Activated Protein Kinase 1-Dependent Manner. |
Q36911360 | Prolonged NF-κB activation by a macrophage inhibitory cytokine 1-linked signal in enteropathogenic Escherichia coli-infected epithelial cells |
Q42860357 | Proteolytic Cleavage of NF-κB p65: A Novel Mechanism for Subversion of Innate Immune Signaling by Pathogenic E. Coli |
Q34375210 | Recent advances in understanding enteric pathogenic Escherichia coli. |
Q89533648 | Revealing eukaryotic histone-modifying mechanisms through bacterial infection |
Q37899039 | Ribosomal protein s3: a multifunctional target of attaching/effacing bacterial pathogens |
Q38522801 | Role of virulence factors on host inflammatory response induced by diarrheagenic Escherichia coli pathotypes |
Q50033878 | Salmonella type III effector SpvC, a phosphothreonine lyase, contributes to reduction in inflammatory response during intestinal phase of infection |
Q27688884 | Structure and mechanism of a type III secretion protease, NleC |
Q57976007 | Structure-function analyses of the bacterial zinc metalloprotease effector protein GtgA uncover key residues required for deactivating NF-κB |
Q41147661 | Substrate recognition by the zinc metalloprotease effector NleC from enteropathogenic Escherichia coli |
Q37951705 | Subversion of innate immune responses by bacterial hindrance of NF-κB pathway |
Q26773133 | Subverting Toll-Like Receptor Signaling by Bacterial Pathogens |
Q38689964 | T3SS-Independent Uptake of the Short-Trip Toxin-Related Recombinant NleC Effector of Enteropathogenic Escherichia coli Leads to NF-κB p65 Cleavage |
Q38643178 | Targeting of host organelles by pathogenic bacteria: a sophisticated subversion strategy |
Q27684732 | The Structure and Specificity of the Type III Secretion System Effector NleC Suggest a DNA Mimicry Mechanism of Substrate Recognition |
Q36200507 | The Type III Effector NleD from Enteropathogenic Escherichia coli Differentiates between Host Substrates p38 and JNK. |
Q42373973 | The WxxxE effector EspT triggers expression of immune mediators in an Erk/JNK and NF-κB-dependent manner |
Q34611109 | The apoptogenic toxin AIP56 is a metalloprotease A-B toxin that cleaves NF-κb P65 |
Q40071930 | The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD). |
Q38255302 | The cell death response to enteropathogenic Escherichia coli infection |
Q28478223 | The enteropathogenic E. coli (EPEC) Tir effector inhibits NF-κB activity by targeting TNFα receptor-associated factors |
Q38071791 | The impact of Toll-like receptors on bacterial virulence strategies |
Q39256913 | The long polar fimbriae of STEC O157:H7 induce expression of pro-inflammatory markers by intestinal epithelial cells. |
Q39495822 | The pathogenic Escherichia coli type III secreted protease NleC degrades the host acetyltransferase p300. |
Q34596147 | The type III secretion effector NleF of enteropathogenic Escherichia coli activates NF-κB early during infection |
Search more.